nieuws



UK wants GSK's Avandia pulled as EU reviews safety

 

GlaxoSmithKline's diabetes drug Avandia should be pulled from sale because of concerns about heart risks, British drug regulators said on Monday ahead of a special European meeting on the drug's safety.

Link


[ Terug naar het hoofdmenu ]